Researchers at Yale School of Medicine have used lab-grown human nasal tissue to show that a fast interferon response can ...
Ainos (AIMD) announced progress in advancing its oral interferon drug platform, Veldona in the rare disease space. The Taiwan FDA has approved the company’s clinical trial for human immunodeficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback